290 results on '"Bertini R."'
Search Results
2. The effect of metabolic syndrome on long-term renal function after partial nephrectomy
3. Clinical characteristics of patients with renal cancer do impact more than ischemia time on post-operative renal function
4. Renal tumor heterogeneity in sporadic and inherited renal cancer: a translational multimodal approach
5. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer
6. Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320)
7. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy
8. The learning curve of radical nephrectomy for kidney cancer: implications for surgical training
9. Oncologic outcomes in patients diagnosed with PT3A non-metastatic renal cell cancer according to renal vein thrombus or fat invasion
10. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
11. Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses
12. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel Lindau renal cell carcinoma
13. Application of the keynote-564 trial results to real life population: which patients with advanced kidney cancer should receive adjuvant pembrolizumab
14. Imaging intensity after surgery for clear cell renal cell carcinoma
15. Risks and benefits of partial nephrectomy with limited or without ischemia time
16. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
17. Surgical treatment for Von Hippel Lindau renal cell carcinoma: analysis of clinical outcomes from the san raffaele VHL program
18. The current role of renal tumor biopsy in small renal masses: long-term results from a prospective, single-institutional database
19. Five-year trend of blood and urine cultures in a tertiary-referral urology center for hospitalized patients: a real-life study
20. The learning curve of radical nephrectomy for kidney cancer: Implications for surgical training
21. Neglected lymph nodal metastases in patients with renal cancer: When to extend the anatomical template of lymph node dissection during nephrectomy
22. Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery
23. Precision surgery for Von Hippel-Lindau renal cell carcinoma
24. The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort
25. Imaging intensity after surgery for clear cell renal cell carcinoma
26. Risks and benefits of partial nephrectomy with limited or without ischemia time
27. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma
28. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
29. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma
30. Clinical outcomes of patients with renal cell carcinoma and imperative indication to become anephric: Implications for multidisciplinary board evaluation
31. Frailty status predicts worse postoperative outcomes and long-term oncologic outcomes in patients treated with partial nephrectomy
32. External validation and head-to-head comparison of all the prognostic models recommended by the european association of urology guidelines to predict oncologic outcomes in patients with renal cell carcinoma
33. Preoperative frailty status is a predictor of 90-days readmission in radical cystectomy candidates
34. Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of tumour clinical size on postoperative renal function
35. Papillary renal cell carcinoma type I and II: Two distinct diseases with different clinical and therapeutical implications
36. Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of clinical tumour size on postoperative renal function
37. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach
38. Pathological features and predictors of oncologic outcomes in patients with small renal masses
39. Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function
40. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial (NCT03955393)
41. Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial?
42. The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy
43. The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study
44. Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer
45. Prognostic differences and survival outcomes in patients with papillary renal cell carcinoma subtypes – a comparison between type I VS. type II
46. Active surveillance for small renal masses: a prospective translational study update (NCT03804320)
47. Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach
48. Hypertension and cardiovascular morbidity following radical nephrectomy are only sustained by renal parenchyma loss and cardiovascular morbidity
49. Chronic kidney disease at the time of surgery for renal cancer: How and when is it possible to improve from the baseline renal function? Results from a single tertiary care referral centre
50. The healthier the patient, the longer the ischemia: Surgical implications for partial nephrectomy in the RECORd2 project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.